Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme

References

• Neumann A, Schwarz P, Lindholm L. Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling. Cost Eff Resour Allocation. 2011 Dec;9(1):17.
   PubMedGoogle Scholar
• Roberts S, Barry E, Craig D, et al. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open. 2017 Nov 1;7(11):e017184.
   PubMed Web of Science ®Google Scholar
• Statista. Estimated number of diabetics worldwide in 2019 and 2045. 2019. [Online]. [cited 2020 Jan 15]. Available from: https://www.statista.com/statistics/271442/number-of-diabetics-worldwide/. Accessed 2020 Jan 15
   Google Scholar
• NHS England. NHS Diabetes Prevention Programme (NHS DPP). 2019. [ONLINE]. [cited 2019 Dec 16]. Available from: https://www.england.nhs.uk/diabetes/diabetes-prevention/
   Google Scholar
• Hex N, Bartlett C, Wright D, et al. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Med. 2012 Jul;29(7):855–862.
   PubMed Web of Science ®Google Scholar
• Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. Bmj. 2008 May 22;336(7654):1180–1185.
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Tucker DM. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Prim Care Diabetes. 2012 Jul 1;6(2):109–121.
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical Excellence. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. 2012. [Online]. [cited 2019 Jul 1]. Available from: https://www.pennine-gp-training.co.uk/res/Diabetes%20screening%20NICE.pdf.
   Google Scholar
• Mainous AG, Tanner RJ, Baker R, et al. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open. 2014 May 1;4(6):e005002.
   PubMed Web of Science ®Google Scholar
• NHS England. NHS health check. [ONLINE]. [cited 2019 Jul 15]. Availablefrom: https://www.nhs.uk/conditions/nhs-health-check/.
   Google Scholar
• Herman WH. The cost-effectiveness of diabetes prevention: results from the diabetes prevention program and the diabetes prevention program outcomes study. Clin Diabetes Endocrinol. 2015Dec1;1(1):9.
   PubMedGoogle Scholar
• NHS England. NHS Diabetes Prevention Programme overview and FAQ. [Online]. [cited 2019 Jun 7]. Available from: https://www.england.nhs.uk/wp-content/uploads/2016/08/dpp-faq.pdf.
   Google Scholar
• Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009 Nov 14; 374(9702):1677–1686.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343–1350.
   PubMed Web of Science ®Google Scholar
• Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 Nov 11;368(9548):1673–1679.
   PubMed Web of Science ®Google Scholar
• Penn L, Rodrigues A, Haste A, et al. NHS diabetes prevention programme in England: formative evaluation of the programme in early phase implementation. BMJ Open. 2018 Feb 1;8(2). https://doi.org/10.1136/bmjopen-2017-019467.
   Google Scholar
• Stokes J, Gellatly J, Bower P, et al. Implementing a national diabetes prevention programme in England: lessons learned. BMC Health Serv Res. 2019 Dec;19(1):1–2.
   PubMed Web of Science ®Google Scholar
• Rodrigues AM, Haste A, Penn L, et al. Stakeholders’ perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers. BMC Health Serv Res. 2020 Dec;20(1):1–3.
   Web of Science ®Google Scholar
• Barron E, Clark R, Hewings R, et al. Progress of the Healthier You: NHS Diabetes Prevention Programme: referrals, uptake and participant characteristics. Diabetic Med. 2018 Apr;35(4):513–518.
   PubMed Web of Science ®Google Scholar
• Aziz Z, Absetz P, Oldroyd J, et al. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015 Dec;10(1):172.
   PubMedGoogle Scholar
• Thompson B, Thompson LA, Andersen MR, et al. Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital. Prev Med. 2002 Jul 1;35(1):87–96.
   PubMed Web of Science ®Google Scholar
• Gannon M, Dowling M. Increasing the uptake of cervical screening programmes. British Journal of Nursing. 2008 Nov 13;17(20):1280–1284.
   PubMedGoogle Scholar
• Shankleman J, Massat NJ, Khagram L, et al. Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer. 2014 Sep;111(7):1440–1447.
   PubMed Web of Science ®Google Scholar
• Tsiachristas A, Gittins M, Kitchener H, et al. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC). J Med Screen. 2018 Jun;25(2):99–109.
   PubMed Web of Science ®Google Scholar
• Filby A, Lewis L, Taylor M. An economic evaluation of interventions to improve the uptake of vitamin D supplements in England and Wales. In: PH56. National institute for health and care excellence. York Health Economics Consortium; 2014.
   Google Scholar
• Thomas C, Sadler S, Breeze P, et al. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open. 2017 Aug 1;7(8):e014953.
   PubMed Web of Science ®Google Scholar
• Leal J, Reed SD, Patel R, et al. Benchmarking the cost-effectiveness of interventions delaying diabetes: a simulation study based on NAVIGATOR data. Diabetes Care. 2020;43(10):2485–2492.
   PubMed Web of Science ®Google Scholar
• Abel L, Shinkins B, Smith A, et al. Early economic evaluation of diagnostic technologies: experiences of the NIHR diagnostic evidence co-operatives. Med Decis Mak. 2019 Oct;39(7):857–866.
   PubMed Web of Science ®Google Scholar
• Faria R, Walker S, Whyte S, et al. How to invest in getting cost-effective technologies into practice? A framework for value of implementation analysis applied to novel oral anticoagulants. Med Decis Mak. 2017 Feb;37(2):148–161.
   PubMed Web of Science ®Google Scholar
• Howarth E, Bower PJ, Kontopantelis E, et al. ‘Going the distance’: an independent cohort study of engagement and dropout among the first 100 000 referrals into a large-scale diabetes prevention program. BMJ Open Diabetes Res Care. 2020Dec1;8(2):e001835.
   PubMed Web of Science ®Google Scholar
• Hinde S, Horsfield L, Bojke L, et al. The relevant perspective of economic evaluations informing local decision makers: an exploration in weight loss services. Appl Health Econ Health Policy. 2019 Dec;4:1–6.
   Google Scholar
• National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2013. [Online]. [cited 2019 Jun 3]. Available from: https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf2007975843781.
   Google Scholar
• Gray AM, Clarke PM, Wolstenholme JL, et al. Applied methods of cost-effectiveness analysis in healthcare. Oxford University Press; 2011.
   Google Scholar
• Roberts S, Craig D, Adler A, et al. Economic evaluation of type 2 diabetes prevention programmes: Markov model of low-and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia. BMC Med. 2018 Dec;16(1):16.
   PubMedGoogle Scholar
• Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Mar 1;142(5):323–332.
   PubMed Web of Science ®Google Scholar
• Morris DH, Khunti K, Achana F, et al. Progression rates from HbA 1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia. 2013;56(7):1489–1493.
   PubMed Web of Science ®Google Scholar
• Balk EM, Earley A, Raman G, et al. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task force. Ann Intern Med. 2015 Sep 15;163(6):437–451.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Muller DC, Nathan DM, et al. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes. 2003 Jun 1;52(6):1475–1484.
   PubMed Web of Science ®Google Scholar
• Office of National Statistics. National life tables UK. 2018. [Online]. [cited 2019 Aug 5]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesunitedkingdomreferencetables.
   Google Scholar
• Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008 Mar;1(3):287–292.
   Google Scholar
• Bächle C, Claessen H, Andrich S, et al. Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study. BMJ Open Diabetes Res Care. 2016 May 1;4(1):e000172.
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical Excellence. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. Costing template. 2012. [Online]. [cited 2019 Jul 15]. Available from: https://www.nice.org.uk/guidance/ph38/resources.
   Google Scholar
• Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford University Press, Oxford; 2006 Aug 18.
   Google Scholar
• Ashra NB, Spong R, Carter P, et al. A systematic review and meta-analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes mellitus in routine practice. London: Public Health England; 2015 Aug.
   Google Scholar
• Neumann A, Schoffer O, Norström F, et al. Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten Sweden. Health Qual Life Outcomes. 2014 Dec 1;12(1):150.
   PubMedGoogle Scholar
• Sutton AJ, Lamont JV, Evans RM, et al. An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer. PloS One. 2018;13(8).
   Web of Science ®Google Scholar
• Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group–6. Med Decis Mak. 2012 Sep;32(5):722–732.
   PubMed Web of Science ®Google Scholar
• Strong M, Oakley JE, Brennan A. Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach. Med Decis Mak. 2014 Apr;34(3):311–326.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. 2017. Putting NICE guidance into practice. Resource impact template: type 2 diabetes: prevention in people at high risk (PH38). [Online]. {cited 2019 Oct 16]. Available from: https://www.nice.org.uk/guidance/ph38/resources.
   Google Scholar
• Frempong SN, Sutton AJ, Davenport C, et al. Early economic evaluation to identify the necessary test characteristics of a new typhoid test to be cost Effective in Ghana. PharmacoEconomics-open. 2020 Mar;4(1):143–157.
   PubMed Web of Science ®Google Scholar